← Back to Search

Cognitive Behavioral Therapy

Digital CBT for Anxiety in Cardiovascular Disease Patients

N/A
Recruiting
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, week 6, and week 10 (post-treatment)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether digital cognitive behavioral therapy (dCBT) is an acceptable treatment for generalized anxiety disorder (GAD) in people with cardiovascular disease (CVD), and whether it is better than a waitlist control condition.

Who is the study for?
This trial is for adults over 18 who've had a recent acute cardiovascular event like a heart attack or stroke and are experiencing anxiety. They must be past the initial recovery phase, which means at least 2 months since their cardiac event, and have clinical levels of generalized anxiety.
What is being tested?
The study is testing a digital Cognitive Behavioral Therapy (dCBT) app called Daylight to see if it helps people with heart disease manage anxiety and improve health behaviors. Participants will either use the dCBT app or be put on a waitlist as part of the control group.
What are the potential side effects?
Since this intervention involves digital therapy rather than medication, traditional side effects are not expected. However, users may experience discomfort or emotional distress when confronting anxious thoughts during therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, week 6, and week 10 (post-treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0, week 6, and week 10 (post-treatment) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Anxiety Sensitivity Inventory (ASI-3)
Cardiac Anxiety Questionnaire Fear Subscale (CAQ-Fear)
Center for Epidemiological Studies Depression Scale 10 Item Version
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital Cognitive Behavior Therapy (dCBT) for Generalized Anxiety DisorderExperimental Treatment1 Intervention
Group II: Waitlist ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
120 Previous Clinical Trials
13,272 Total Patients Enrolled

Media Library

Daylight dCBT Application (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04895995 — N/A
Cardiovascular Disease Research Study Groups: Waitlist Control, Digital Cognitive Behavior Therapy (dCBT) for Generalized Anxiety Disorder
Cardiovascular Disease Clinical Trial 2023: Daylight dCBT Application Highlights & Side Effects. Trial Name: NCT04895995 — N/A
Daylight dCBT Application (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04895995 — N/A
Cardiovascular Disease Patient Testimony for trial: Trial Name: NCT04895995 — N/A
~25 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top